
Medaica is a digital health company that develops an FDA-cleared AI and sensor-based auscultation platform for early detection of heart and lung conditions. Their platform includes low-cost acoustic biomarker sensors, AI diagnostics, and interoperable software for patients and healthcare professionals, enabling affordable at-home self-screening and remote diagnostics. Medaica's patented technology supports real-time lossless audio streaming and decision support for murmur detection. The company targets chronic cardiac and pulmonary diagnostics with a scalable cloud platform validated for secure clinical-grade audio transmission. Medaica aims to make remote care accessible and affordable globally, focusing on value-based healthcare and open interoperability to accelerate innovation and improve outcomes.

Medaica is a digital health company that develops an FDA-cleared AI and sensor-based auscultation platform for early detection of heart and lung conditions. Their platform includes low-cost acoustic biomarker sensors, AI diagnostics, and interoperable software for patients and healthcare professionals, enabling affordable at-home self-screening and remote diagnostics. Medaica's patented technology supports real-time lossless audio streaming and decision support for murmur detection. The company targets chronic cardiac and pulmonary diagnostics with a scalable cloud platform validated for secure clinical-grade audio transmission. Medaica aims to make remote care accessible and affordable globally, focusing on value-based healthcare and open interoperability to accelerate innovation and improve outcomes.
What they do: FDA-cleared AI + sensor telehealth auscultation platform for heart and lung screening
Flagship product: Medaica M1 Telehealth Stethoscope (FDA 510(k) cleared; OTC-cleared)
Headquarters: Henderson, Nevada, USA
Team size (approx.): 12 employees
Funding disclosed: Total funding reported as 330,000 USD (per provided data)
Early detection and remote monitoring of cardiac and pulmonary conditions via acoustic biomarkers and telehealth workflows.
Digital health / Medical devices
Crunchbase indicates a Seed round exists but amount/date details are obfuscated in provided sources.